NSEGranting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals▲ PositiveRegulatory15 Oct 2026
Ather Energy Limited
Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals
Ather Energy Limited has received a Certificate of Registration from IRDAI to act as a Corporate Agent (Composite) for distribution and servicing of life, general and health insurance business.
BSECompany Update▲ PositiveResults15 Oct 2026
Popular Vehicles and Services Ltd
In accordance with SEBI LODR Regulations, 2015 and Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information in terms of Regulation 8 of the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has provided a business update for the quarter and half year ended 30th September, 2026.
Popular Vehicles and Services Ltd reported a strong, broad-based YoY growth in new vehicle volumes in Q2FY27 and H1FY27, driven by healthy organic growth across the existing network and contributions from recent acquisitions. The company also witnessed encouraging customer demand and strong sales momentum during the festive season, with demand expected to remain positive through the upcoming festive period.
BSECompany Update▲ PositiveResults15 Oct 2026
HCL Technologies Ltd
Enclosed please find an earnings call transcript.
HCL Technologies Ltd. announced its Q2 FY27 earnings, with a solid quarter driven by Advanced AI services, new bookings, and margin expansion. The company reported a 2.3% sequential revenue growth and a 2.6% YoY growth, with Advanced AI revenue reaching $219 million, up 28.4% sequentially and 78% YoY. The EBIT margin improved to 18.2%, an increase of 131 basis points sequentially and 71 basis points YoY.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults15 Oct 2026
HCL Technologies Limited
Analysts/Institutional Investor Meet/Con. Call Updates
HCL Technologies Limited has informed the Exchange about the transcript of the Conference Call held on October 12, 2026, post the announcement of the financial results of the Company for the quarter ended September 30, 2026.
NSEPress Release▲ PositiveResults15 Oct 2026
Kabra Extrusion Technik Limited
Press Release
Kabra Extrusion Technik Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a significant increase in revenue, EBITDA, and PAT.
BSECompany Update▲ PositiveResults15 Oct 2026
Kabra Extrusiontechnik Ltd
Press Release
Kabra Extrusiontechnik Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, showing a significant increase in revenue, EBITDA, and PAT. The company's Geon division has led the growth, with revenues up 2.5 times year-on-year and contributing 75% of consolidated revenues in Q2 FY27.
NSEGeneral Updates▲ PositiveFundraise15 Oct 2026
Prestige Estates Projects Limited
General Updates
Prestige Estates Projects Limited has informed the Exchange about the consummation of the first tranche of the transaction in its Hospitality Portfolio through a strategic partnership with CPP Investment Board Private Holdings (4) Inc. and Prestige Hospitality Ventures Limited. The transaction involves the acquisition of 10% and 5.79% of PHVL's shareholding by CPPIB for a total consideration of INR 1,500,00,00,000.
BSECompany Update▲ PositiveFundraise15 Oct 2026
Prestige Estates Projects Ltd
In continuation with earlier announcements dated August 10, 2026, and September 29, 2026, the Company has consummated the first tranche of transaction in Hospitality Portfolio through strategic partnership with CPP Investments.
Prestige Estates Projects Ltd has consummated the first tranche of its transaction in the Hospitality Portfolio through a strategic partnership with CPP Investments, acquiring 10% and 5.79% of PHVL's shareholding for INR 950,00,00,000 and INR 550,00,00,000 respectively.
NSEPress Release▲ PositiveResults15 Oct 2026
Mangalam Worldwide Limited
Press Release
Mangalam Worldwide Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a 31% YoY increase in PAT to ₹13.82 crores and a 13.4% YoY growth in total income to ₹361 crores. The company has also incorporated a wholly owned subsidiary in Belgium to expand its international presence.
BSEResult▲ PositiveResults15 Oct 2026
SBC Exports Ltd
Result for the Quarter and Half Year Ended on 30th September 2026
SBC Exports Ltd has announced its results for the quarter and half year ended on 30th September 2026, with a net profit of ₹1080.14 crore and a total comprehensive income of ₹1086.53 crore. The company's revenue from operations was ₹13,831.19 crore, and its expenses were ₹12,866.61 crore. The earnings per share from continuing operations was ₹0.23.
BSECompany Update▲ PositiveExpansion15 Oct 2026
Indian Railway Catering and Tourism Corporation Ltd
Please find attached herewith Press Release.
IRCTC has partnered with Quality Council of India (QCI) for a digital, third-party food safety and hygiene audit across its catering units.
NSEPress Release▲ PositiveExpansion15 Oct 2026
Indian Railway Catering And Tourism Corporation Limited
Press Release
IRCTC partners with Quality Council of India (QCI) for digital, third-party food safety and hygiene audit, ensuring rigorous compliance with FSSAI regulations and international culinary standards.
BSECompany Update▲ PositiveResults15 Oct 2026
L&T Finance Ltd
Please find attached the press release for Q2FY2026-27
L&T Finance Ltd reported its Q2FY27 results, with a 33% YoY increase in consolidated PAT to Rs. 975 Crore, and a 28% YoY growth in consolidated book to Rs. 1,36,635 Crore. The company also achieved its highest ever consolidated book and retail disbursements.
NSEPress Release▲ PositiveM&A15 Oct 2026
Mankind Pharma Limited
Press Release
Mankind Pharma Limited has announced that its Board of Directors has approved the acquisition of a majority stake (70%) in Armed Cell Therapeutics B.V. (ACTx), a Belgium-incorporated biotechnology company, through its wholly-owned subsidiary Mankind Pharma (Netherlands) B.V. The acquisition is part of the Company's long-term strategy to build a global innovation-led pharmaceutical business.
NSEPress Release▲ PositiveResults15 Oct 2026
L&T Finance Limited
Press Release
L&T Finance Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with a consolidated Profit After Tax (PAT) of Rs. 975 Crore, up 33% YoY, and a consolidated book of Rs. 1,36,635 Crore, up 28% YoY.
BSECompany Update▲ PositiveM&A15 Oct 2026
Mankind Pharma Ltd
Please find attached press release titled "Mankind Pharma to Acquire Majority Stake in Armed Cell Therapeutics, Marking Strategic Entry into Next-Generation CAR-T Therapies".
Mankind Pharma Ltd has announced that its Board of Directors has approved the acquisition of a majority stake (70%) in Armed Cell Therapeutics B.V. (ACTx), a Belgium-incorporated biotechnology company, through its wholly-owned subsidiary Mankind Pharma (Netherlands) B.V. The acquisition is part of the company's long-term strategy to build a global innovation-led pharmaceutical business.
NSEAcquisition▲ PositiveM&A15 Oct 2026
Mankind Pharma Limited
Acquisition
Mankind Pharma Limited has informed the Exchange about Acquisition of majority stake (70%) in Armed Cell Therapeutics B.V. (ACTx) through its wholly-owned subsidiary Mankind Pharma (Netherlands) B.V. for EUR 48Mn in installments.
BSECompany Update▲ PositiveM&A15 Oct 2026
Mankind Pharma Ltd
Please find attached intimation regarding investment by the Company.
Mankind Pharma Ltd has announced an investment of up to EUR 45Mn in its wholly-owned subsidiary Mankind Pharma (Netherlands) B.V. to acquire a 70% stake in Armed Cell Therapeutics B.V. (ACTx), a Belgium-incorporated biotechnology company developing next-generation CAR-T therapies for cancer.
NSEOutcome of Board Meeting▲ PositiveM&A15 Oct 2026
Mankind Pharma Limited
Outcome of Board Meeting
Mankind Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on October 15, 2026. The Board of Directors has considered and approved an additional investment of up to EUR 45Mn in Mankind Pharma (Netherlands) B.V. and the acquisition of a majority stake (i.e., 70%) in Armed Cell Therapeutics B.V. through Mankind Netherlands.
NSEPress Release▲ PositiveResults15 Oct 2026
Sri Lotus Developers and Realty Limited
Press Release
Sri Lotus Developers and Realty Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with strong Q2 FY27 momentum, including 83% YoY growth in pre-sales to INR 470 Crs, 53% YoY growth in total revenue to INR 269 Crs, and 113% YoY growth in EBITDA to INR 107 Crs.